Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering a novel SERPING1 pathogenic variant: insights into the aggregation of C1-INH in hereditary angioedema. | Orphanet J Rare Dis | 2024 | 39272138 | PubTator, text mining | PubMed |
| Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients. | J Neuroimmunol | 2024 | 39255718 | PubTator, text mining | PubMed |
| Study on Preclinical Safety and Toxic Mechanism of Human Umbilical Cord Mesenchymal Stem Cells in F344RG Rats. | Stem Cell Rev Rep | 2024 | 39243336 | PubTator, text mining | PubMed |
| Hereditary angioedema presented as isolated ascending and transverse colon swelling mimicking acute abdomen. | SAGE Open Med Case Rep | 2024 | 39224758 | PubTator, text mining | PubMed |
| Increased Pan-Type, A1-Type, and A2-Type Astrocyte Activation and Upstream Inflammatory Markers Are Induced by the P2X7 Receptor. | Int J Mol Sci | 2024 | 39201471 | PubTator, text mining | PubMed |
| [Two pediatric hereditary angioedemathe families: case report and literature review]. | Zhonghua Er Ke Za Zhi | 2024 | 39192448 | PubTator, text mining | PubMed |
| Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus. | Eur J Immunol | 2024 | 39165045 | PubTator, text mining | PubMed |
| Realising gene therapy: a biomedical challenge. | EBioMedicine | 2024 | 39152007 | PubTator, text mining | PubMed |
| Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications. | Osteoporos Int | 2024 | 39120624 | PubTator, text mining | PubMed |
| Causal relationship between complement C1QB and colorectal cancer: a drug target Mendelian randomization study. | Front Genet | 2024 | 39109334 | PubTator, text mining | PubMed |
| Structural basis for the inhibition of βFXIIa by garadacimab. | Structure | 2024 | 39059382 | PubTator, text mining | PubMed |
| Determinants of Disease Activity in Adults With Hereditary Angioedema due to C1-Esterase Inhibitor Deficiency. | J Investig Allergol Clin Immunol | 2024 | 39056466 | PubTator, text mining | PubMed |
| sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID. | iScience | 2024 | 39027374 | PubTator, text mining | PubMed |
| The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation. | J Immunol | 2024 | 38995166 | PubTator, text mining | PubMed |
| Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study. | Allergy Asthma Proc | 2024 | 38982603 | PubTator, text mining | PubMed |
| Case Report: Early presentation of hereditary angioedema symptoms in a 2-year-old boy. | Front Pediatr | 2024 | 38978843 | PubTator, text mining | PubMed |
| Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review. | Orphanet J Rare Dis | 2024 | 38978028 | PubTator, text mining | PubMed |
| The Burden of Hereditary Angioedema in a Large Family in Brazil. | Int Arch Allergy Immunol | 2024 | 38964293 | PubTator, text mining | PubMed |
| Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema. | N Engl J Med | 2024 | 38959481 | PubTator, text mining | PubMed |
| Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization. | Immunol Allergy Clin North Am | 2024 | 38937015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=14